Aetnas typical PA requirements for Wegovy and Zepbound include: Documented BMI of 30 or higher, or BMI of 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea) Evidence of participation in a structured weight management program (diet, exercise, behavioral counseling) for a minimum period often 3 to 6 months Documentation that other weight loss interventions have been attempted Prescriber must be a physician, NP, or PA with appropriate prescribing authority Prior authorization is not a denial it is a documentation requirement
But real-world data tells a more nuanced story
Gallant Therapeutics
Semaglutide is self-administered as a subcutaneous injection in the abdomen, thigh, or upper arm
The effectiveness of the Skinny IV Drip in shedding excess body weight has been reported by many clients who have seen significant improvements in their weight loss journeys
However, compounded versions may carry additional risks due to quality variability